A citation-based method for searching scientific literature

Wagner Gouvêa Dos Santos. Biomed Pharmacother 2021
Times Cited: 19







List of co-cited articles
91 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.
Chuan Qin, Luoqi Zhou, Ziwei Hu, Shuoqi Zhang, Sheng Yang, Yu Tao, Cuihong Xie, Ke Ma, Ke Shang, Wei Wang,[...]. Clin Infect Dis 2020
26

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Lindsey R Baden, Hana M El Sahly, Brandon Essink, Karen Kotloff, Sharon Frey, Rick Novak, David Diemert, Stephen A Spector, Nadine Rouphael, C Buddy Creech,[...]. N Engl J Med 2021
26

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
21

Pathological findings of COVID-19 associated with acute respiratory distress syndrome.
Zhe Xu, Lei Shi, Yijin Wang, Jiyuan Zhang, Lei Huang, Chao Zhang, Shuhong Liu, Peng Zhao, Hongxia Liu, Li Zhu,[...]. Lancet Respir Med 2020
21

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Fernando P Polack, Stephen J Thomas, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L Perez, Gonzalo Pérez Marc, Edson D Moreira, Cristiano Zerbini,[...]. N Engl J Med 2020
21

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial.
Raches Ella, Krishna Mohan Vadrevu, Harsh Jogdand, Sai Prasad, Siddharth Reddy, Vamshi Sarangi, Brunda Ganneru, Gajanan Sapkal, Pragya Yadav, Priya Abraham,[...]. Lancet Infect Dis 2021
103
21

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu,[...]. Lancet 2020
21

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Merryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, Lily Y Weckx, Pedro M Folegatti, Parvinder K Aley, Brian Angus, Vicky L Baillie, Shaun L Barnabas, Qasim E Bhorat,[...]. Lancet 2021
21


Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
James M Sanders, Marguerite L Monogue, Tomasz Z Jodlowski, James B Cutrell. JAMA 2020
15

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.
Carly G K Ziegler, Samuel J Allon, Sarah K Nyquist, Ian M Mbano, Vincent N Miao, Constantine N Tzouanas, Yuming Cao, Ashraf S Yousif, Julia Bals, Blake M Hauser,[...]. Cell 2020
15

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.
Xiuyuan Ou, Yan Liu, Xiaobo Lei, Pei Li, Dan Mi, Lili Ren, Li Guo, Ruixuan Guo, Ting Chen, Jiaxin Hu,[...]. Nat Commun 2020
15

Genotype and phenotype of COVID-19: Their roles in pathogenesis.
Leila Mousavizadeh, Sorayya Ghasemi. J Microbiol Immunol Infect 2021
284
15

Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.
Cheryl Keech, Gary Albert, Iksung Cho, Andreana Robertson, Patricia Reed, Susan Neal, Joyce S Plested, Mingzhu Zhu, Shane Cloney-Clark, Haixia Zhou,[...]. N Engl J Med 2020
444
15

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.
Shengli Xia, Yuntao Zhang, Yanxia Wang, Hui Wang, Yunkai Yang, George Fu Gao, Wenjie Tan, Guizhen Wu, Miao Xu, Zhiyong Lou,[...]. Lancet Infect Dis 2021
277
15

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.
Denis Y Logunov, Inna V Dolzhikova, Olga V Zubkova, Amir I Tukhvatullin, Dmitry V Shcheblyakov, Alina S Dzharullaeva, Daria M Grousova, Alina S Erokhova, Anna V Kovyrshina, Andrei G Botikov,[...]. Lancet 2020
363
15

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.
Alexandra C Walls, Young-Jun Park, M Alejandra Tortorici, Abigail Wall, Andrew T McGuire, David Veesler. Cell 2020
15

Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.
Jerald Sadoff, Mathieu Le Gars, Georgi Shukarev, Dirk Heerwegh, Carla Truyers, Anne M de Groot, Jeroen Stoop, Sarah Tete, Wim Van Damme, Isabel Leroux-Roels,[...]. N Engl J Med 2021
372
15

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.
Feng-Cai Zhu, Xu-Hua Guan, Yu-Hua Li, Jian-Ying Huang, Tao Jiang, Li-Hua Hou, Jing-Xin Li, Bei-Fang Yang, Ling Wang, Wen-Juan Wang,[...]. Lancet 2020
494
15

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2.
Hui Wang, Yuntao Zhang, Baoying Huang, Wei Deng, Yaru Quan, Wenling Wang, Wenbo Xu, Yuxiu Zhao, Na Li, Jin Zhang,[...]. Cell 2020
258
15

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19.
Yuan Huang, Chan Yang, Xin-Feng Xu, Wei Xu, Shu-Wen Liu. Acta Pharmacol Sin 2020
413
15

COVID-19 Vaccine: A comprehensive status report.
Simran Preet Kaur, Vandana Gupta. Virus Res 2020
212
15

Advances in mRNA Vaccines for Infectious Diseases.
Cuiling Zhang, Giulietta Maruggi, Hu Shan, Junwei Li. Front Immunol 2019
204
15


A Novel Coronavirus from Patients with Pneumonia in China, 2019.
Na Zhu, Dingyu Zhang, Wenling Wang, Xingwang Li, Bo Yang, Jingdong Song, Xiang Zhao, Baoying Huang, Weifeng Shi, Roujian Lu,[...]. N Engl J Med 2020
10

A pneumonia outbreak associated with a new coronavirus of probable bat origin.
Peng Zhou, Xing-Lou Yang, Xian-Guang Wang, Ben Hu, Lei Zhang, Wei Zhang, Hao-Rui Si, Yan Zhu, Bei Li, Chao-Lin Huang,[...]. Nature 2020
10

COVID-19 and diabetes: Knowledge in progress.
Akhtar Hussain, Bishwajit Bhowmik, Nayla Cristina do Vale Moreira. Diabetes Res Clin Pract 2020
268
10

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Philippe Gautret, Jean-Christophe Lagier, Philippe Parola, Van Thuan Hoang, Line Meddeb, Morgane Mailhe, Barbara Doudier, Johan Courjon, Valérie Giordanengo, Vera Esteves Vieira,[...]. Int J Antimicrob Agents 2020
10

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
Roujian Lu, Xiang Zhao, Juan Li, Peihua Niu, Bo Yang, Honglong Wu, Wenling Wang, Hao Song, Baoying Huang, Na Zhu,[...]. Lancet 2020
10

Viral targets for vaccines against COVID-19.
Lianpan Dai, George F Gao. Nat Rev Immunol 2021
225
10

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.
Andrew Rambaut, Edward C Holmes, Áine O'Toole, Verity Hill, John T McCrone, Christopher Ruis, Louis du Plessis, Oliver G Pybus. Nat Microbiol 2020
726
10

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.
Nicholas G Davies, Sam Abbott, Rosanna C Barnard, Christopher I Jarvis, Adam J Kucharski, James D Munday, Carl A B Pearson, Timothy W Russell, Damien C Tully, Alex D Washburne,[...]. Science 2021
633
10

Laboratory diagnosis of emerging human coronavirus infections - the state of the art.
Michael J Loeffelholz, Yi-Wei Tang. Emerg Microbes Infect 2020
353
10

COVID-19 vaccines: where we stand and challenges ahead.
Guido Forni, Alberto Mantovani. Cell Death Differ 2021
181
10

Profiles of current COVID-19 vaccines.
Franz X Heinz, Karin Stiasny. Wien Klin Wochenschr 2021
8
25

A single-cell atlas of the peripheral immune response in patients with severe COVID-19.
Aaron J Wilk, Arjun Rustagi, Nancy Q Zhao, Jonasel Roque, Giovanny J Martínez-Colón, Julia L McKechnie, Geoffrey T Ivison, Thanmayi Ranganath, Rosemary Vergara, Taylor Hollis,[...]. Nat Med 2020
501
10

COVID-19 vaccines: modes of immune activation and future challenges.
John R Teijaro, Donna L Farber. Nat Rev Immunol 2021
90
10

Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.
Divij Mathew, Josephine R Giles, Amy E Baxter, Derek A Oldridge, Allison R Greenplate, Jennifer E Wu, Cécile Alanio, Leticia Kuri-Cervantes, M Betina Pampena, Kurt D'Andrea,[...]. Science 2020
583
10

Characterization of accessory genes in coronavirus genomes.
Christian Jean Michel, Claudine Mayer, Olivier Poch, Julie Dawn Thompson. Virol J 2020
53
10

Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).
Bo Diao, Chenhui Wang, Yingjun Tan, Xiewan Chen, Ying Liu, Lifen Ning, Li Chen, Min Li, Yueping Liu, Gang Wang,[...]. Front Immunol 2020
947
10

Correction: Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.
Li Tan, Qi Wang, Duanyang Zhang, Jinya Ding, Qianchuan Huang, Yi-Quan Tang, Qiongshu Wang, Hongming Miao. Signal Transduct Target Ther 2020
292
10

Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.
Li Tan, Qi Wang, Duanyang Zhang, Jinya Ding, Qianchuan Huang, Yi-Quan Tang, Qiongshu Wang, Hongming Miao. Signal Transduct Target Ther 2020
591
10

Clinical and immunological features of severe and moderate coronavirus disease 2019.
Guang Chen, Di Wu, Wei Guo, Yong Cao, Da Huang, Hongwu Wang, Tao Wang, Xiaoyun Zhang, Huilong Chen, Haijing Yu,[...]. J Clin Invest 2020
10

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.
Alba Grifoni, Daniela Weiskopf, Sydney I Ramirez, Jose Mateus, Jennifer M Dan, Carolyn Rydyznski Moderbacher, Stephen A Rawlings, Aaron Sutherland, Lakshmanane Premkumar, Ramesh S Jadi,[...]. Cell 2020
10

Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
Vibhuti Kumar Shah, Priyanka Firmal, Aftab Alam, Dipyaman Ganguly, Samit Chattopadhyay. Front Immunol 2020
100
10

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19.
Mingfeng Liao, Yang Liu, Jing Yuan, Yanling Wen, Gang Xu, Juanjuan Zhao, Lin Cheng, Jinxiu Li, Xin Wang, Fuxiang Wang,[...]. Nat Med 2020
899
10

Intracellular Pathogens: Host Immunity and Microbial Persistence Strategies.
Aneesh Thakur, Heidi Mikkelsen, Gregers Jungersen. J Immunol Res 2019
71
10

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Maheshi N Ramasamy, Angela M Minassian, Katie J Ewer, Amy L Flaxman, Pedro M Folegatti, Daniel R Owens, Merryn Voysey, Parvinder K Aley, Brian Angus, Gavin Babbage,[...]. Lancet 2021
444
10

Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.
Eakachai Prompetchara, Chutitorn Ketloy, Tanapat Palaga. Asian Pac J Allergy Immunol 2020
667
10

COVID-19, SARS and MERS: are they closely related?
N Petrosillo, G Viceconte, O Ergonul, G Ippolito, E Petersen. Clin Microbiol Infect 2020
445
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.